ALJ Rogers Sets Procedural Schedule in Inv. No. 337-TA-766
ALJ Robert K. Rogers, Jr. issued an order on April 4, 2011 that set the procedural schedule in Inv. No. 337-TA-766, Certain Gemcitabine and Products Containing the Same. The target date of July 23, 2012 is set to conclude the investigation between Complainant Eli Lilly and Company and Respondents Intas Pharmaceuticals, inc., Hospira, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd., and Chem Werth Inc.
